BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22123462)

  • 1. Mitoxantrone in combination with a DNA-PK inhibitor: possible therapy of promyelocytic leukaemia resistant forms.
    Mikusová V; Tichý A; Rezáčová M; Vávrová J
    Folia Biol (Praha); 2011; 57(5):200-5. PubMed ID: 22123462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topoisomerase II is required for mitoxantrone to signal nuclear factor kappa B activation in HL60 cells.
    Boland MP; Fitzgerald KA; O'Neill LA
    J Biol Chem; 2000 Aug; 275(33):25231-8. PubMed ID: 10940316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of Double-Strand Break Repair Proteins to Viral Replication Compartments following Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
    Hollingworth R; Horniblow RD; Forrest C; Stewart GS; Grand RJ
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28855246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective use of an alternative stop codon and polyadenylation signal within intron sequences leads to a truncated topoisomerase II alpha messenger RNA and protein in human HL-60 leukemia cells selected for resistance to mitoxantrone.
    Harker WG; Slade DL; Parr RL; Holguin MH
    Cancer Res; 1995 Nov; 55(21):4962-71. PubMed ID: 7585537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line.
    Harker WG; Slade DL; Parr RL; Feldhoff PW; Sullivan DM; Holguin MH
    Cancer Res; 1995 Apr; 55(8):1707-16. PubMed ID: 7712479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitoxantrone resistance in HL-60 leukemia cells: reduced nuclear topoisomerase II catalytic activity and drug-induced DNA cleavage in association with reduced expression of the topoisomerase II beta isoform.
    Harker WG; Slade DL; Drake FH; Parr RL
    Biochemistry; 1991 Oct; 30(41):9953-61. PubMed ID: 1655025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-dependent protein kinase regulates DNA end resection in concert with Mre11-Rad50-Nbs1 (MRN) and ataxia telangiectasia-mutated (ATM).
    Zhou Y; Paull TT
    J Biol Chem; 2013 Dec; 288(52):37112-25. PubMed ID: 24220101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ku regulates the non-homologous end joining pathway choice of DNA double-strand break repair in human somatic cells.
    Fattah F; Lee EH; Weisensel N; Wang Y; Lichter N; Hendrickson EA
    PLoS Genet; 2010 Feb; 6(2):e1000855. PubMed ID: 20195511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-PK: a dynamic enzyme in a versatile DSB repair pathway.
    Davis AJ; Chen BP; Chen DJ
    DNA Repair (Amst); 2014 May; 17():21-9. PubMed ID: 24680878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Mcl-1 confers multidrug resistance, whereas topoisomerase IIβ downregulation introduces mitoxantrone-specific drug resistance in acute myeloid leukemia.
    Hermanson DL; Das SG; Li Y; Xing C
    Mol Pharmacol; 2013 Aug; 84(2):236-43. PubMed ID: 23696245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficiency of homologous recombination and non-homologous end joining systems in repairing double-strand breaks during cell cycle progression.
    Bee L; Fabris S; Cherubini R; Mognato M; Celotti L
    PLoS One; 2013; 8(7):e69061. PubMed ID: 23874869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TDP1 is required for efficient non-homologous end joining in human cells.
    Li J; Summerlin M; Nitiss KC; Nitiss JL; Hanakahi LA
    DNA Repair (Amst); 2017 Dec; 60():40-49. PubMed ID: 29078113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCR/ABL downregulates DNA-PK(CS)-dependent and upregulates backup non-homologous end joining in leukemic cells.
    Poplawski T; Blasiak J
    Mol Biol Rep; 2010 Jun; 37(5):2309-15. PubMed ID: 19697154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRE11-RAD50-NBS1 complex dictates DNA repair independent of H2AX.
    Yuan J; Chen J
    J Biol Chem; 2010 Jan; 285(2):1097-104. PubMed ID: 19910469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleolin mediates nucleosome disruption critical for DNA double-strand break repair.
    Goldstein M; Derheimer FA; Tait-Mulder J; Kastan MB
    Proc Natl Acad Sci U S A; 2013 Oct; 110(42):16874-9. PubMed ID: 24082117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the Mre11-Rad50-Nbs1 complex in double-strand break repair-facts and myths.
    Takeda S; Hoa NN; Sasanuma H
    J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i25-i32. PubMed ID: 27311583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP puts the brake on DNA double-strand break repair: a new study shows that ATP switches the Mre11-Rad50-Nbs1 repair factor between signaling and processing of DNA ends.
    Hopfner KP
    Bioessays; 2014 Dec; 36(12):1170-8. PubMed ID: 25213441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for topoisomerase II alpha in the formation of radiation-induced chromatid breaks.
    Terry SY; Riches AC; Bryant PE
    Br J Cancer; 2008 Aug; 99(4):670-4. PubMed ID: 18665175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription-coupled DNA double-strand breaks are mediated via the nucleotide excision repair and the Mre11-Rad50-Nbs1 complex.
    Guirouilh-Barbat J; Redon C; Pommier Y
    Mol Biol Cell; 2008 Sep; 19(9):3969-81. PubMed ID: 18632984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of non-homologous end joining in Fanconi Anemia cells results in rescue of survival after interstrand crosslinks but sensitization to replication associated double-strand breaks.
    Eccles LJ; Bell AC; Powell SN
    DNA Repair (Amst); 2018 Apr; 64():1-9. PubMed ID: 29459202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.